Welcome to #1 DIGITAL HEALTH NEWS Portal

Innovative Medicines Initiative Launches 100th Project

The Innovative Medicines Initiative (IMI) has launched its 100th project in the form of Hypo-RESOLVE, a 4 year, EUR 26.8 million project on diabetes. The milestone comes as IMI celebrates its 10th anniversary with a series of events and activities. The IMI project portfolio is diverse; many projects, like Hypo-RESOLVE, focus on specific health issues such as diabetes, neurological conditions (including dementia, depression, and pain), cancer, auto-immune diseases (such as rheumatoid arthritis), and infectious diseases (including antimicrobial resistance and Ebola).

Read more ...

The Big Ethical Questions for Artificial Intelligence in Healthcare

AI in healthcare is developing rapidly, with many applications currently in use or in development in the UK and worldwide. The Nuffield Council on Bioethics examines the current and potential applications of AI in healthcare, and the ethical issues arising from its use, in a new briefing note, Artificial Intelligence (AI) in healthcare and research, published today.

Read more ...

International Master's in Medical Informatics at the Heart of Europe

The Master of Science Program in Medical Informatics (MMI) at European Campus Rottal-Inn (ECRI) in Pfarrkirchen - a branch of the Deggendorf University of Applied Sciences (THD - Technische Hochschule Deggendorf) in Bavaria, Germany - is accepting applications for entry in October 2018.

Read more ...

Philips, Emory Healthcare and Royal Perth Hospital in Australia Partner to Launch New Remote Intensive Care Monitoring Program

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and US-based Emory Healthcare have launched a new remote Intensive Care Unit (eICU) monitoring program, based at the Royal Perth Hospital in Western Australia, focused on improving the outcomes of high risk patients and advancing the globalization of critical care.

Read more ...

Computer-Designed Customized Regenerative Heart Valves

Producing living tissue or organs based on human cells is one of the main research fields in regenerative medicine. Tissue engineering, which involves growing replacement parts in the laboratory, forms a key part of this research. The parts can be used to replace defective cells and tissues in the body and restore their normal functioning.

Read more ...

Applications for the G4A Global Accelerator Are Now Open

Founded in 2013 in Berlin initially giving out grants to innovative healthcare apps, G4A Accelerator is now a global program dedicated to helping innovative health & care startups grow and enable positive disruption and progress within the digital health & care universe.

Read more ...

Philips Expands its Sleep & Respiratory Care Portfolio with the Acquisition of NightBalance

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it has acquired NightBalance, a digital health scale-up company based in the Netherlands, that has developed an innovative, easy to use device to treat positional obstructive sleep apnea and positional snoring. Financial details of the transaction were not disclosed.

Read more ...

A New Way to Watch Brain Activity in Action

It's a neuroscientist's dream: being able to track the millions of interactions among brain cells in animals that move about freely, behaving as they would under natural circumstances. New technology developed at The Rockefeller University represents a big step toward realizing that goal.

Read more ...

Siemens Healthineers Fully on Track to Meet the Targets

Siemens Healthineers AG has posted good business figures in the first quarter following its successful initial public offering on March 16, 2018. Year-over-year revenue was up four percent at EUR 3.2 billion on a comparable basis. Despite continuing negative currency effects, the profit margin adjusted for non-recurring effects increased by 90 basis points to 17.4 percent, while adjusted profit was stable at EUR 560 million compared to the second quarter of 2017.

Read more ...

Gait Assessed with Body-Worn Sensors may Help Detect Onset of Alzheimer's Disease

Body-worn sensors used at home and in clinic by people with mild Alzheimer's to assess walking could offer a cost-effective way to detect early disease and monitor progression of the illness. A pilot study involving Newcastle University, UK, has revealed low-cost wearable devices could improve clinical trial efficiency and encourage research investment. Identification of clinical biomarkers, such as changes in walking characteristics and behaviours, are known to be important factors when looking at early warning signs of dementia.

Read more ...